The national health insurance program leaves many older Americans without adequate resources to properly maintain their sight, a new study finds.

To combat growing eye problems and treatment disparities in communities of color, a U-M effort works to foster a more diverse group of eye care providers.

Immunotherapy cancer drugs can cause a potentially vision-robbing side effect. In a new report, Michigan Medicine experts discuss the risks and what oncologists should know.

Medication for diabetic eye disease is crucial, but it’s hard to tell in advance when and how often patients might need it. New research aims to provide insight.

A new study links familial relationships to the likelihood older adults will get needed cataract surgery - a procedure with broad implications for health.

A complex camera has the potential to help doctors get a clearer, more accurate look at the human eye. How a trio of U-M experts from different fields made the discovery.

Both eye surgeries have the same intent — though they are different. A Michigan Medicine ophthalmologist explains how he helps patients make the best choice.

Deciding to get LASIK surgery requires thought and evaluation. Here’s what an ophthalmologist tells prospective recipients

Ophthalmologists take photos of a patient’s eyes to monitor good health and track progress of disease. Here are some common ways the images are taken.

People with type 1 and 2 diabetes are at risk of diabetic retinopathy. Learn about diabetic retinopathy symptoms and treatment.

Falls among middle-aged people are an underreported issue, U-M researchers say. Now, they’re probing the connection between falling and poor vision as a way to prevent injury.

Low vision can instill a fear of falling, which keeps many older adults homebound. A U-M occupational therapist outlines guidelines for getting around safely.

Seeing double is a fairly common issue — that can be serious. That’s why both eye specialists and primary care providers should be prepared to address it.

Tim Anegon’s wife and daughter recently connected with the U-M scientists working with his eye tissue donation — and saw the gift’s outsize impact.

An analysis of Medicare Part D data reveals that a preference among eye care providers for name-brand medication has systemwide cost implications.